These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 10694240)

  • 1. Primary porcine enterocyte and hepatocyte cultures to study drug oxidation reactions.
    Bader A; Hansen T; Kirchner G; Allmeling C; Haverich A; Borlak JT
    Br J Pharmacol; 2000 Jan; 129(2):331-42. PubMed ID: 10694240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytochrome P450 enzyme activity and protein expression in primary porcine enterocyte and hepatocyte cultures.
    Hansen T; Borlak J; Bader A
    Xenobiotica; 2000 Jan; 30(1):27-46. PubMed ID: 10659949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolism of tacrolimus (FK 506) in rat liver microsomes. Effect of rifampin and dexamethasone.
    Prasad ; Tata NV; Subbotina N; Burckart G; Swaminathan A; Gusev AI; Hercules DM; Venkataramanan R
    Res Commun Mol Pathol Pharmacol; 1997 Apr; 96(1):107-10. PubMed ID: 9178371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase I and phase II drug-metabolizing enzymes are expressed and heterogeneously distributed in the biliary epithelium.
    Lakehal F; Wendum D; Barbu V; Becquemont L; Poupon R; Balladur P; Hannoun L; Ballet F; Beaune PH; Housset C
    Hepatology; 1999 Dec; 30(6):1498-506. PubMed ID: 10573530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of the metabolism of midazolam by rifampin in cultured porcine hepatocytes: preliminary evidence for CYP3A isoforms in pigs.
    Hosagrahara VP; Hansen LK; Remmel RP
    Drug Metab Dispos; 1999 Dec; 27(12):1512-8. PubMed ID: 10570035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolism of the immunosuppressant tacrolimus in the small intestine: cytochrome P450, drug interactions, and interindividual variability.
    Lampen A; Christians U; Guengerich FP; Watkins PB; Kolars JC; Bader A; Gonschior AK; Dralle H; Hackbarth I; Sewing KF
    Drug Metab Dispos; 1995 Dec; 23(12):1315-24. PubMed ID: 8689938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tacrolimus (FK 506) biotransformation in primary rat hepatocytes depends on extracellular matrix geometry.
    Bader A; Knop E; Böker KH; Crome O; Frühauf N; Gonschior AK; Christians U; Esselmann H; Pichlmayr R; Sewing KF
    Naunyn Schmiedebergs Arch Pharmacol; 1996 Mar; 353(4):461-73. PubMed ID: 8935714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolism of the macrolide immunosuppressant, tacrolimus, by the pig gut mucosa in the Ussing chamber.
    Lampen A; Christians U; Gonschior AK; Bader A; Hackbarth I; von Engelhardt W; Sewing KF
    Br J Pharmacol; 1996 Apr; 117(8):1730-4. PubMed ID: 8732283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxidation of 1,8-cineole, the monoterpene cyclic ether originated from eucalyptus polybractea, by cytochrome P450 3A enzymes in rat and human liver microsomes.
    Miyazawa M; Shindo M; Shimada T
    Drug Metab Dispos; 2001 Feb; 29(2):200-5. PubMed ID: 11159812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overlapping substrate specificities of cytochrome P450 3A and P-glycoprotein for a novel cysteine protease inhibitor.
    Zhang Y; Guo X; Lin ET; Benet LZ
    Drug Metab Dispos; 1998 Apr; 26(4):360-6. PubMed ID: 9531525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolism and transport of the macrolide immunosuppressant sirolimus in the small intestine.
    Lampen A; Zhang Y; Hackbarth I; Benet LZ; Sewing KF; Christians U
    J Pharmacol Exp Ther; 1998 Jun; 285(3):1104-12. PubMed ID: 9618413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Omeprazole and lansoprazole are mixed inducers of CYP1A and CYP3A in human hepatocytes in primary culture.
    Curi-Pedrosa R; Daujat M; Pichard L; Ourlin JC; Clair P; Gervot L; Lesca P; Domergue J; Joyeux H; Fourtanier G
    J Pharmacol Exp Ther; 1994 Apr; 269(1):384-92. PubMed ID: 8169844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of the rabbit and human cytochromes P-450IIIA as the major enzymes involved in the N-demethylation of diltiazem.
    Pichard L; Gillet G; Fabre I; Dalet-Beluche I; Bonfils C; Thenot JP; Maurel P
    Drug Metab Dispos; 1990; 18(5):711-9. PubMed ID: 1981725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytochrome P450 Involvement in the biotransformation of cisapride and racemic norcisapride in vitro: differential activity of individual human CYP3A isoforms.
    Pearce RE; Gotschall RR; Kearns GL; Leeder JS
    Drug Metab Dispos; 2001 Dec; 29(12):1548-54. PubMed ID: 11717173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of extracellular matrix overlay and medium formulation on the induction of cytochrome P-450 2B enzymes in primary cultures of rat hepatocytes.
    LeCluyse E; Bullock P; Madan A; Carroll K; Parkinson A
    Drug Metab Dispos; 1999 Aug; 27(8):909-15. PubMed ID: 10421618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Catalytic activities, protein- and mRNA-expression of cytochrome P450 isoenzymes in intestinal cell lines.
    Lampen A; Bader A; Bestmann T; Winkler M; Witte L; Borlak JT
    Xenobiotica; 1998 May; 28(5):429-41. PubMed ID: 9622846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of CYP3A5 polymorphism on tacrolimus metabolic clearance in vitro.
    Dai Y; Hebert MF; Isoherranen N; Davis CL; Marsh C; Shen DD; Thummel KE
    Drug Metab Dispos; 2006 May; 34(5):836-47. PubMed ID: 16501005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced cyclophosphamide and ifosfamide activation in primary human hepatocyte cultures: response to cytochrome P-450 inducers and autoinduction by oxazaphosphorines.
    Chang TK; Yu L; Maurel P; Waxman DJ
    Cancer Res; 1997 May; 57(10):1946-54. PubMed ID: 9157990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implication of CYP 3A in the toxicity of cyclosporin G (CsG), cyclosporin A (CsA) and FK506 on rat hepatocytes in primary culture.
    Ellouk-Achard S; Martin C; Pham-Huy C; Duc HT; Thevenin M; Dutertre-Catella H; Warnet JM; Claude JR
    Arch Toxicol; 1997; 71(7):437-42. PubMed ID: 9209689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin differentially affects xenobiotic-enhanced, cytochrome P-450 (CYP)2E1, CYP2B, CYP3A, and CYP4A expression in primary cultured rat hepatocytes.
    Woodcroft KJ; Novak RF
    J Pharmacol Exp Ther; 1999 May; 289(2):1121-7. PubMed ID: 10215695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.